Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single-cell sequencing across radiation treatment timepoints in head and neck cancer

ABSTRACT: Single-cell sequencing across radiation treatment timepoints in head and neck cancer

PROVIDER: PRJNA1181774 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR31216800_1.fastq.gz	Fastqsanger.gz
	SRR31216800_2.fastq.gz	Fastqsanger.gz
	SRR31216801_1.fastq.gz	Fastqsanger.gz
	SRR31216801_2.fastq.gz	Fastqsanger.gz
	SRR31216802.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 85

Similar Datasets

Single-cell sequencing across radiation treatment timepoints in head and neck cancer

Project description:We performed single cell sequencing across treatment timepoints to evaluate the immunological impact of radiation in head and neck cancer.

2025-04-23 | GSE280982 | GEO

Redox proteomics analysis of head and neck cancer cell model of radiation resistance

Project description:Quantitative redox proteomics analysis was performed using the SCC-61/rSCC-61 matched model system of radiation resistance in human head and neck squamous cell carcinoma.

2023-03-10 | PXD029053 | Pride

Mevalonate pathway activity is a key determinant of radiation sensitivity in head and neck cancer

Project description:Radioresistance is a major hurdle in the treatment of head and neck squamous cell carcinoma (HNSCC). Here we report a novel role for statin-based treatment of HNSCCs as an actionable and safe adjuvant to radiotherapy. Proteomic profiling and comparison of radiosensitive and radioresistant HNSCCs revealed differential regulation of the mevalonate biosynthetic pathway. Consistent with this finding, inhibition of the mevalonate pathway by pitavastatin (and other related statins) sensitized SQ20B cells to ionizing radiation (IR) and reduced their clonogenic potential. In an effort to uncover the mechanism behind this statin-mediated sensitization, we analyzed prenylation of several important cellular targets upon combined IR-statin treatment. Overall, this study reinforces the view that the mevalonate pathway is a promsing novel therapeutic target in radioresistant HSNCCs.

2019-06-25 | PXD007188 | Pride

Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer

Project description:RATIONALE: Gathering information about patients’ quality of life during radiation therapy for cancer may help doctors plan the best treatment. PURPOSE: This randomized clinical trial is studying quality of life in patients undergoing radiation therapy for primary lung cancer, head and neck cancer, or gastrointestinal cancer.

| 2067438 | ecrin-mdr-crc

A new model: radiation and cigarette smoke promote an aggressive cell phenotype and gene signature in head and neck cancer cells. and gene signature in head and neck cancer cells.

Project description:Background and purpose: Mucosal Head and Neck squamous cell cancers (HNSCCs) are aggressive invasive cancers. They arise in the oral cavity, oropharynx, nasopharynx, hypopharynx and larynx. To control local disease, radiation is used curatively and palliatively to destroy or reduce the tumour load. Smokers are at increased risk of developing these cancers, and smoking whilst receiving radiation worsens survival rates. However, the cellular and molecular mechanisms underlying this has not been well described. We developed a model to elucidate the effects of radiation and smoking and the pathways involved. This will enable the identification of novel pharmaceutical targets for patient trials. Materials & Methods: FaDu hypopharyngeal cancer cells were subjected to a fractionated daily radiation procedure and cultured in smoke exposed media. Cells were examined for changes in tumoursphere number, proliferation, migration, invasion, CD44 and ALDH1 expression, and next generation sequencing was performed. Immunohistochemistry compared CD44 and ALDH1 expression in never-smokers and smokers. Results: Radiation and smoking separately reduced FaDu Cancer Stem Cell (CSC) number and proliferation, and increased cell migration and invasion. Combined they further reduced CSC number and proliferation, and promoted migration. Through sequencing radiation and smoking produced a unique gene signature related to cell invasion, angiogenesis, and survival. CD44 expression and ALDH activity decreased after co-treatment and their expression did not associate with smoking status in a small patient cohort.

2025-04-12 | GSE224803 | GEO

Gene expression analysis in high risk head and neck squamous cell carcinoma treated with post-operative radiotherapy

Project description:Post-operative radiation therapy (PORT) is the standard treatment for patients with head and neck squamous cell carcinoma (HNSCC) having adverse pathological features. Despite PORT, many patients develop relapse causing morbidity and mortality. These specimens are from a high-risk cohort of such patients treated by PORT and are being used to develop gene signatures for therapeutic response.

2022-03-16 | GSE67614 | GEO

Head and neck squamous cell carcinoma

Project description:Quantitative (iTRAQ 4-plex) proteomic analysis of progressive head and neck cancers

2022-03-01 | PXD001438 | Pride

Gene expression profiles of head and neck squamous cell carcinoma

Project description:Sage performed on microdissection of Head and Neck tumor, and Head and Neck normal tissue comparative analysis of gene expression profiles of head and neck squamous cell carcinoma and Head and Neck normal tissue

2008-09-30 | E-GEOD-11986 | biostudies-arrayexpress

RNA-seq of head and neck cancer cell lines

Project description:Transcriptome analysis in head and neck cancer cell lines, FaDu and UMSCC47 with and without 5-aza'2-deoxycytidine(Aza)/trichostatin A(TSA) treatment.

2018-05-10 | GSE98805 | GEO

Gene expression profiles of head and neck squamous cell carcinoma

Project description:Sage performed on microdissection of Head and Neck tumor, and Head and Neck normal tissue

2008-09-30 | GSE11986 | GEO